Article ; Online: Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy.
2020 Volume 6, Issue 7, Page(s) 550–558
Abstract: The use of immune checkpoint therapies targeting programmed death-1 (PD-1) and its ligand (PD-L1) continue to show limited durable success in clinical cases despite widespread application. While some patients achieve complete responses and disease ... ...
Abstract | The use of immune checkpoint therapies targeting programmed death-1 (PD-1) and its ligand (PD-L1) continue to show limited durable success in clinical cases despite widespread application. While some patients achieve complete responses and disease remission, others are completely resistant to the therapy. Recent evidence in the field suggests that tumor-derived exosomes could be responsible for mediating systemic immunosuppression that antagonizes anti-PD-1 checkpoint therapy. In this Opinion article, we discuss our claim that endogenous tumor exosomal PD-L1 and tumor-derived exosome-induced PD-L1 are two of the most notable mechanisms of exosome-mediated resistance against antitumor immunity and we discuss how this resistance could directly influence immune checkpoint therapy failure. |
---|---|
MeSH term(s) | Animals ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; B7-H1 Antigen/antagonists & inhibitors ; B7-H1 Antigen/immunology ; B7-H1 Antigen/metabolism ; Disease Progression ; Drug Resistance, Neoplasm/drug effects ; Drug Resistance, Neoplasm/immunology ; Exosomes/drug effects ; Exosomes/immunology ; Exosomes/metabolism ; Humans ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Macrophages/immunology ; Macrophages/metabolism ; Mice ; Neoplasms/drug therapy ; Neoplasms/immunology ; T-Lymphocytes, Cytotoxic/immunology ; Treatment Failure ; Tumor Burden/drug effects ; Tumor Burden/immunology ; Tumor Escape/drug effects ; Tumor Microenvironment/drug effects ; Tumor Microenvironment/immunology ; Xenograft Model Antitumor Assays |
Chemical Substances | B7-H1 Antigen ; CD274 protein, human ; Cd274 protein, mouse ; Immune Checkpoint Inhibitors |
Language | English |
Publishing date | 2020-03-29 |
Publishing country | United States |
Document type | Journal Article ; Review |
ZDB-ID | 2852626-0 |
ISSN | 2405-8025 ; 2405-8033 ; 2405-8033 |
ISSN (online) | 2405-8025 ; 2405-8033 |
ISSN | 2405-8033 |
DOI | 10.1016/j.trecan.2020.03.002 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.